Deutsches Krebsforschungszentrum (DKFZ)

Real-world management of patients with complete response under immune-checkpoint inhibition for advanced melanoma (2025) Reitmajer M, Livingstone E, Thoms KM, Heppt M, Meiss F, Gesierich A, Drexler K, et al. Journal article The sarcoma ring trial: a case-based analysis of inter-center agreement across 21 German-speaking sarcoma centers (2025) Roohani S, Handtke J, Hummedah K, Albertsmeier M, Andreou D, Apostolidis L, Augustin M, et al. Journal article Hyperreactive B cells instruct their elimination by T cells to curb autoinflammation and lymphomagenesis. (2025) Diehl C, Soberón V, Baygün S, Chu Y, Mandelbaum J, Kraus L, Engleitner T, et al. Journal article Treatment of Advanced or Metastatic Urothelial Cancer (2025) Hilser T, Darr C, Bedke J, Ivanyi P, Klümper N, Eckstein M, Schlack K, Grünwald V Journal article, Review article Correction to: Genetic drivers and cellular selection of female mosaic X chromosome loss (Nature, (2024), 631, 8019, (134-141), 10.1038/s41586-024-07533-7) (2024) Liu A, Genovese G, Zhao Y, Pirinen M, Zekavat SM, Kentistou KA, Yang Z, et al. Journal article, Erratum Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer (2024) Nelson BH, Hamilton P, Phung MT, Milne K, Harris B, Thornton S, Stevens D, et al. Journal article Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction (2024) Yiangou K, Mavaddat N, Dennis J, Zanti M, Wang Q, Bolla MK, Abubakar M, et al. Journal article Development of a novel immunocompetent murine tumor model for urothelial carcinoma using in vivo electroporation (2024) Soleder S, Gengenbacher N, Mogler C, Eckstein M, Runge A, Kriegmair MC, Augustin HG Journal article DNA Methylation Profiling of Salivary Gland Tumors Supports and Expands Conventional Classification (2024) Jurmeister P, Leitheiser M, Arnold A, Capilla EP, Mochmann LH, Zhdanovic Y, Schleich K, et al. Journal article Physical activity levels are positively related to progression-free survival and reduced adverse events in advanced ER+ breast cancer (2024) Zimmer P, Esser T, Lueftner D, Schuetz F, Baumann FT, Rody A, Schneeweiss A, et al. Journal article